| Literature DB >> 29387043 |
Fateme Barancheshme1, Mariya Munir1.
Abstract
The main goal of this manuscript is to review different treatment strategies and mechanisms for combating the antibiotic resistant bacteria (ARB) and antibiotic resistant genes (ARGs) in the wastewater environment. The high amount of antibiotics is released into the wastewater that may promote selection of ARB and ARGs which find their way into natural environments. Emerging microbial pathogens and increasing antibiotic resistance among them is a global public health issue. The propagation and spread of ARB and ARGs in the environment may result in an increase of antibiotic resistant microbial pathogens which is a worldwide environmental and public health concern. A proper treatment of wastewater is essential before its discharge into rivers, lake, or sewage system to prevent the spread of ARB and ARGs into the environment. This review discusses various treatment options applied for combating the spread of ARB and ARGs in wastewater treatment plants (WWTPs). It was reported that low-energy anaerobic-aerobic treatment reactors, constructed wetlands, and disinfection processes have shown good removal efficiencies. Nanomaterials and biochar combined with other treatment methods and coagulation process are very recent strategies regarding ARB and ARGs removal and need more investigation and research. Based on current studies a wide-ranging removal efficiency of ARGs can be achieved depending on the type of genes present and treatment processes used, still, there are gaps that need to be further investigated. In order to find solutions to control dissemination of antibiotic resistance in the environment, it is important to (1) study innovative strategies in large scale and over a long time to reach an actual evaluation, (2) develop risk assessment studies to precisely understand occurrence and abundance of ARB/ARGs so that their potential risks to human health can be determined, and (3) consider operating and environmental factors that affect the efficiency of each treatment mechanism.Entities:
Keywords: antibiotic resistant bacteria; antibiotic resistant genes; biochar; coagulation; disinfection; nanomaterial; treatment strategies; wastewater treatment
Year: 2018 PMID: 29387043 PMCID: PMC5776126 DOI: 10.3389/fmicb.2017.02603
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Antibiotics concentrations in the WWTP and receiving river (Xu et al., 2015).
| WWTP influent | 1615.8 | 2263.0 | 3664.0 |
| WWTP effluent | 195.0 | 2001.0 | 3866.0 |
| Upstream | 265.2 | 648.1 | 728.8 |
| Downstream | 345.1 | 1111.0 | 2769.0 |
The release of adsorbed Ofloxacin from sludge or suspended particles may contribute to the high level of quinolones at this site.
WHO priority pathogens that need new antibiotics (Lawe-Davies and Bennett, 2017).
| Carbapenem | |
| Carbapenem | |
| Carbapenem, ESBL | |
| Vancomycin | |
| Methicillin, vancomycin-intermediate, and resistant | |
| Clarithromycin | |
| Fluoroquinolone | |
| Fluoroquinolone | |
| Cephalosporin, fluoroquinolone | |
| Penicillin-non-susceptible | |
| Ampicillin | |
| Fluoroquinolone | |
Extended Spectrum Beta-Lactamases. The ESBL enzyme breaks down and destroys most antibiotics causing them to be inactive, which is why they are not effective against infections caused by these types of bacteria.
Removal of ARGs by different treatment processes.
| – | Du et al., | |
| 2.37 to 7.06 | Munir et al., | |
| 1.21 | Ye et al., | |
| 0.44 to 0.80 | Chen et al., | |
| 0.39 to 0.65 removal rates of total 14 targeted ARGs | Fang et al., | |
| 0.1 to 2.3 | Li H. et al., | |
| 0.42 and 0.10 removal of | Yuan et al., | |
| 1.30 to 1.49 | Sharma et al., | |
| 0.5 to 3.1 | Li N. et al., | |
Conventional treatment plants and MBR facility.
Nanoparticles combating ARB and ARGs.
| Nanosilver and sulfamethoxazole | Sulfamethoxazole Anaerobic Digester Sludge | ARGs: | Miller et al., |
| Silver nanoparticles | An aquatic environment with Fe3+ or Fe2+ ions and natural organic matter | ARB: | Adegboyega et al., |
| Silver | Aqueous solution | ARB: | Singh et al., |
| Nitric oxide releasing nanoparticles | Aqueous solution | ARB: | |
| Silver nanoparticles with NOM and Iron | Aqueous solution | ARB: methicillin-resistant | Sharma et al., |
| Nanoparticles including copper oxide (CuO), zinc oxide (ZnO), and TiO2 | Aqueous environment | ARB: | Pavithra et al., |
| Ceftriaxone- ZnO Nanorods | Aquatic solutions of E. coli with ceftriaxone, ZnO nanorods and ceftriaxone-ZnO nanorods with phosphate-buffered solution | ARB: | Luo et al., |
| Superparamagnetic iron oxide nanoparticles (conjugation of iron, zinc, and silver) | Treatment of medical device infections | ARB: multi- drug resistant | Taylor et al., |
| Nano alumina | Water | ARB: | Qiu et al., |
| Gold nanoparticles with vancomycin | Aqueous solution of polyvinyl alcohol | ARB: vancomycin resistant | Mohammed Fayaz et al., |
| Iron oxide nanoparticles | Aqueous solution | ARB: | Tran et al., |